To evaluate the impact of FOXK1 cooperating with FHL2 on tumour growth in vivo, we inoculated vector, FOXK1 stable transfectants and Lenti-FOXK1–FHL2-shRNA into BALB/c-nu/nu mice, as shown in Figure 6a. Here, FHL2 is linked to neoplasm.